Promoter holding
64.27%
BB
Brawn Biotech Limited - Due diligence report
A 360° intelligence report on Brawn Biotech Limited: trust score, financial health, credit view, compliance, directors, growth and distress …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Brawn Biotech Limited — 360° Intelligence Report
Generated from MCA filings & public records62/100
Trust Score
Moderate
Brawn Biotech Limited is assessed as Moderate with a Trust Score of 62/100. Brawn Biotech Limited is an active public limited indian non-government company incorporated in 1985, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 18 Jul 2026 from the latest processed filings. Brawn Biotech Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 4 satisfied (30.28 Lakh).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Punjab National Bank | 4 | 48.0 cr |
Compliance Score: 55/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE, CDSL.
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (5 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| BRIJ RAJ GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BRIJ BALA GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pooja Pandey | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MAYANK JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRIYANKA SHARMA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pooja Jha | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a majority stake - exact percentages are part of the full report.
Key managerial personnel: Pooja Pandey (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 50
Growth signals & trust indicators
Operating for 40+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
3 director exits within 2 years.
Compliance score is weak (55/100).
MSME payment delays disclosed - latest outstanding 97,210.00.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence56/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view46/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events25 Nov 2025
Director ceased
BRIJ BALA GUPTA
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
MAYANK JAIN
Director ceased
Pooja Jha
27 Aug 2024
Director appointed
MAYANK JAIN (Director)
Director appointed
Pooja Jha (Director)
05 Aug 2022
Director appointed
Pooja Pandey (CFO)
10 Sep 2019
Director ceased
ARUN MUDGAL
13 Aug 2019
Director ceased
BRIJ RAJ GUPTA
20 Feb 2019
Charge satisfied
Punjab National Bank
15 Feb 2019
Charge satisfied
Punjab National Bank
01 Jan 2019
Director appointed
PRIYANKA SHARMA (Company Secretary)
22 Sep 2018
Director ceased
KANTA TAKKAR
Director ceased
SUBHASH CHANDER
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
6 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
All 4 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Bombay Vyapar (Exports) Private Limited | U22219MH1950PTC008272 | Mumbai, Maharashtra, India |
| Jabico Steels Private Limited | U74899DL1991PTC044506 | New Delhi, Delhi, India |
| Mupnar Real Estate Pvt. Ltd. | U70109WB1991PTC052175 | Kolkata, West Bengal, India |
| Balaji Marketing Agencies (Bombay) Pvt Ltd | U51900MH1992PTC065896 | Mumbai, Maharashtra, India |
| Sadhana Synthetics Private Limited | U17120GJ2010PTC060134 | Surat, Gujarat, India |
| Jai Hanuman Cloth Agencies Private Limited | U51311MH2003PTC141306 | Mumbai, Maharashtra, India |
| Skva Rubber Solutions | U25205MH2017PTC294271 | Mumbai, Maharashtra, India |
| Maharaja India Vintrade Private Limited | U52599MP2013PTC029880 | Indore, Madhya Pradesh, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Brawn Biotech Limited before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Brawn Biotech Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Brawn Biotech Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Brawn Biotech Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Brawn Biotech Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Brawn Biotech Limited an active company?
Brawn Biotech Limited has MCA status “Active” with a compliance score of 55/100 (Moderate).
Is Brawn Biotech Limited financially healthy?
Brawn Biotech Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Brawn Biotech Limited?
Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Brawn Biotech Limited?
Promoters hold a majority stake - exact percentages are in the full report. 6 active director(s) are on record.
Does Brawn Biotech Limited have loans or charges against its assets?
No open charges - all 4 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Brawn Biotech Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 55/100 (Moderate).
Is it risky to lend to Brawn Biotech Limited?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
